InvestorsHub Logo
Followers 20
Posts 1059
Boards Moderated 0
Alias Born 04/01/2013

Re: jtf3 post# 15023

Friday, 09/27/2013 10:17:27 PM

Friday, September 27, 2013 10:17:27 PM

Post# of 426292
Niaspan had the bad study that came out and if you look at the numbers Vascepa plus Lovaza is pretty comparable to many weeks so it seems the only material drop is in Niaspan.

Niaspin want generic this week so assuming the numbers do not count generic the # should start dropping rapidly but in terms of fish oil prescriptions just seems like Lovaza is dropping and Vascepa is gaining, some weeks you can compare its not as noticeable but the overall trend that is clearly what's happening.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News